Tukysa 150 MG tablet UU 60S
Ended Awarded Last action
- Contract number
- SPE2DR26FG3PA
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $20,036
Award facts
- Contract value 100% obligated
- $20,035.80 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $20,035.80 to Amerisourcebergen Drug Corp (UEI: KABZK8W6PQT3) on January 20, 2026, with a completion date of February 10, 2026. The order is for TUKYSA 150 mg tablets in quantities of 60 units and represents a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The place of performance is Conshohocken, Pennsylvania, which serves as the company's corporate headquarters. This delivery order was issued under Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical supply agreement valued at $999,999,999.00 and extending through December 2026.
Amerisourcebergen Drug Corp, a subsidiary of parent company Cencora, Inc. (doing business as Amerisourcebergen), is a major pharmaceutical distributor serving federal medical procurement needs across the Department of Defense healthcare system. The company supplies an extensive portfolio of pharmaceutical products and medical supplies through its DLA contract vehicle, supporting military treatment facilities and government healthcare systems globally. TUKYSA (tucatinib) is an oncology medication used in breast cancer treatment, consistent with the company's established role delivering specialty medications across multiple therapeutic domains to federal agencies.
Quick answers
Who was awarded contract SPE2DR26FG3PA?
SPE2DR26FG3PA was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 20, 2026.
How much is contract SPE2DR26FG3PA worth?
The government has obligated $20,036 on SPE2DR26FG3PA.
Is contract SPE2DR26FG3PA an order under another contract?
Yes. SPE2DR26FG3PA is a delivery order under SPE2DR25D3016, an indefinite delivery contract.
Was contract SPE2DR26FG3PA competed?
The extent of competition for SPE2DR26FG3PA was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award